MUIR GLENN P Insider Trades

Insider Trading History

Track insider trading activity for MUIR GLENN P. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Cytek BioSciences
Cytek BioSciences CTKB
Director
Holding Value $226k 55,555 shares
Last Trade
Jun 10, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$346k 85,390 shares
$4.05
$4.07
Neuronetics
Neuronetics STIM
Director
Holding Value $490k 401,816 shares
Last Trade
May 28, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$46.2k 30,000 shares
$1.54
$1.22
Repligen
Repligen RGEN
Director
Holding Value $283k 2,239 shares
Last Trade
May 14, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$231k 2,239 shares
$103.38
$126.37
Repligen
Repligen RGEN
Director
Holding Value $5.06M 40,051 shares
Last Trade
May 14, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$103k 995 shares
$103.38
$126.37
Repligen
Repligen RGEN
Director
Holding Value $308k 2,434 shares
Last Trade
May 07, 2026 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$308k 2,434 shares
$126.43
$126.37
Repligen
Repligen RGEN
Director
Holding Value $4.94M 39,056 shares
Last Trade
May 07, 2026 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$308k 2,434 shares
$126.43
$126.37
Repligen
Repligen RGEN
Director
Holding Value $4.63M 36,622 shares
Last Trade
Dec 16, 2025 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$532k 3,366 shares
$158.09
$126.37
Repligen
Repligen RGEN
Director
Holding Value $425k 3,366 shares
Last Trade
Dec 16, 2025 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$532k 3,366 shares
$158.09
$126.37
Neuronetics
Neuronetics STIM
Director
Holding Value $454k 371,816 shares
Last Trade
Oct 20, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$20.6k 7,554 shares
$2.73
$1.22
Neuronetics
Neuronetics STIM
Director
Holding Value $444k 364,262 shares
Last Trade
May 22, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$120k 30,000 shares
$3.99
$1.22
Repligen
Repligen RGEN
Director
Holding Value $4.2M 33,256 shares
Last Trade
May 15, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$222k 1,800 shares
$123.26
$126.37
Neuronetics
Neuronetics STIM
Director
Holding Value $408k 334,262 shares
Last Trade
Feb 07, 2025 Purchase (Other)Another type of insider transaction reported on SEC Form 4.
$139k 44,444 shares
$3.12
$1.22
Repligen
Repligen RGEN
Director
Holding Value $4.08M 32,283 shares
Last Trade
Nov 19, 2024 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$2.44M 19,000 shares
$128.49
$126.37
Repligen
Repligen RGEN
Director
Holding Value $0 0 shares
Last Trade
Nov 19, 2024 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$2.44M 19,000 shares
$128.49
$126.37
G1 Therapeutics
G1 Therapeutics GTHX
Director
Holding Value $0 0 shares
Last Trade
Sep 18, 2024 Sale (Tender)Reported as Tender on SEC Form 4.
$1.33M 185,358 shares
$7.16
$7.16
G1 Therapeutics
G1 Therapeutics GTHX
Director
Holding Value $1.33M 185,358 shares
Last Trade
Sep 18, 2024 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$143k 20,000 shares
$7.15
$7.16
G1 Therapeutics
G1 Therapeutics GTHX
Director
Holding Value $0 0 shares
Last Trade
Sep 18, 2024 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$358k 50,000 shares
$7.16
$7.16
G1 Therapeutics
G1 Therapeutics GTHX
Director
Holding Value $0 0 shares
Last Trade
Sep 18, 2024 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$215k 30,000 shares
$7.16
$7.16
G1 Therapeutics
G1 Therapeutics GTHX
Director
Holding Value $0 0 shares
Last Trade
Sep 18, 2024 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$215k 30,000 shares
$7.16
$7.16
G1 Therapeutics
G1 Therapeutics GTHX
Director
Holding Value $0 0 shares
Last Trade
Sep 18, 2024 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$215k 30,000 shares
$7.16
$7.16

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up